Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.57 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14189198 | 0.92 | USP2 (0.68) | ATMMAPTLMNACYP2D6CYP1A2 | |
| SCHEMBL267463 | 0.88 | LMNA (0.68) | MAPTLMNACYP2D6NPSR1KMT2A | |
| SCHEMBL19021801 | 0.86 | USP2 (0.62) | ATMMAPTLMNACYP2D6CYP1A2 | |
| SCHEMBL9663864 | 0.85 | CA1 (0.55) | ATMMAPTLMNACYP2D6CYP1A2 | |
| SCHEMBL12133451 | 0.85 | USP2 (0.60) | ATMMAPTLMNACYP2D6CYP1A2 | |
| SCHEMBL14546274 | 0.84 | LMNA (0.59) | MAPTLMNACYP2D6KMT2AKDM4E | |
| SCHEMBL13991663 | 0.83 | TSHR (0.58) | MAPTLMNACYP2D6CYP1A2CYP3A4 | |
| SCHEMBL10313439 | 0.83 | USP2 (0.58) | MAPTLMNACYP2D6CYP1A2CYP3A4 | |
| SCHEMBL12881505 | 0.83 | USP2 (0.58) | ATMMAPTLMNACYP2D6CYP1A2 | |
| SCHEMBL16348229 | 0.82 | TSHR (0.62) | ATMMAPTLMNACYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9738774-B2 | Flame retardant for epoxy resin containing phosphonate and phosphinate functionality | ICL-IP AMERICA INC. (US) | 2017-08-22 | — | — | US | disclosed |
| US-9738774-B2 | Flame retardant for epoxy resin containing phosphonate and phosphinate functionality | ICL-IP AMERICA INC. (US) | 2017-08-22 | — | — | US | disclosed |
| US-20160244596-A1 | FLAME RETARDANT FOR EPOXY RESIN CONTAINING PHOSPHONATE AND PHOSPHINATE FUNCTIONALITY | ICL-IP AMERICA INC. | 2016-08-25 | — | — | US | disclosed |
| US-20160244596-A1 | FLAME RETARDANT FOR EPOXY RESIN CONTAINING PHOSPHONATE AND PHOSPHINATE FUNCTIONALITY | ICL-IP AMERICA INC. | 2016-08-25 | — | — | US | disclosed |
| US-20150307746-A1 | LIGNIN DERIVED PHOTO-RESPONSIVE COATINGS | CRESTLINE DIRECT FINANCE, L.P. | 2015-10-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160244596-A1 | FLAME RETARDANT FOR EPOXY RESIN CONTAINING PHOSPHONATE AND PHOSPHINATE FUNCTIONALITY | PFAS, PHOSPHO1, PPA1 | ATM 3052/4885MAPT 1119/4885LMNA 3217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.